The initial aim of drug discovery is to develop compounds that exhibit appropriate safety and efficacy profiles which can be progressed to clinical evaluation. The focus of this Training School will be to explore the principles underlying target identification, biochemical and cell-based assay development, small molecule screening and in-vitro ADME-Tox profiling to produce compounds ready for clinical studies, whilst maintaining low environmental impact.
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. The COST ACTIONS help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
OneHealthdrugs CA21111
Title:
One Health drugs against parasitic vector borne diseases in Europe and beyond
